Extrinsic Immunity Therapeutics Revenue

Biotechnology Research • Ann Arbor Charter Township, Michigan, United States • 1-10 Employees

Extrinsic Immunity Therapeutics revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	No funding

Key Contact at Extrinsic Immunity Therapeutics

Priyan Weerappuli

Co-Founder & Managing Partner

Company overview

Headquarters	Ann Arbor Charter Township, Michigan, United States
Website	eitherapeutics.com
NAICS	541714
Founded	2024
Employees	1-10

About Extrinsic Immunity Therapeutics

A biotechnology startup spun out of the University of Michigan, we are working at the interface between oncology and immunology to develop novel tools to extend the treatment window for solid tumors, and to improve the efficacy of existing treatments.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Extrinsic Immunity Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Extrinsic Immunity Therapeutics has never raised funding before.

Extrinsic Immunity Therapeutics Tech Stack

Discover the technologies and tools that power Extrinsic Immunity Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

reCAPTCHA

Security

Squarespace Commerce

Ecommerce

Stimulus

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

Mailgun

Cart Functionality

Ecommerce

Google Maps

Maps

YUI

JavaScript libraries

Frequently asked questions

Extrinsic Immunity Therapeutics is located in Ann Arbor Charter Township, Michigan, US.

Extrinsic Immunity Therapeutics generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.

Extrinsic Immunity Therapeutics has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Extrinsic Immunity Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Extrinsic Immunity Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Extrinsic Immunity Therapeutics

Priyan Weerappuli

Co-Founder & Managing Partner

4.8

40,000 users